FDA OKs first treatment for rare genetic disorder

WASHINGTON (AP) -- The Food and Drug Administration on Friday approved the first treatment for children and adults with spinal muscular atrophy, a rare genetic disorder marked by progressive muscle weakness that's the most common genetic cause of death in infants....

Read the whole article on AP Health

More from AP Health